Dabigatran etexilate (mesylate), CAS 872728-81-9

Formulation: A solid

Formal Name: N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine, methanesulfonate ethyl ester

Purity: ≥98%

Formula Markup: C34H41N7O5 • CH3SO3H

Formula Weight: 723,8

Shelf life (days): 1460

CAS Number: 872728-81-9

Notes: Dabigatran etexilate is a prodrug form of the thrombin inhibitor dabigatran (Item No. 17133).{62763} It inhibits thrombin-induced platelet aggregation in isolated rabbit platelets (IC50 = 0.337 µM) and inhibits thrombus formation in a rat model of venous thrombosis (ED50 = 7.8 µmol/kg). Formulations containing dabigatran etexilate have been used to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation and in the treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism.

• Artikelnummer: CAY35248-100
• Hersteller: Cayman Chemical
• Hersteller Artikelnummer: 35248-100
• Green Labware: Nein
• Verpackungseinheit: 100 mg
• Mengeneinheit: STK
• Methode: Reinstoffe